BD will equip Columbia Asia’s team of diabetes management specialists on best-in-class insulin injection technique
New Delhi, July 12,2016 : Beginning this week, BD, the medical technology brand will work with diabetes management hospital professionals in Columbia Asia hospitals across India, for a period of nine months through its BD Getting Started program. The aim is to equip diabetes educators with customized solutions and aid clinicians and people with diabetes who are being initiated on insulin. The collaboration will provide a certification to the Diabetes Educators who will be imparted knowledge and intensive hands-on training.
The BD Getting Started is a Diabetes educational resource program for insulin users. It is a collaboratively designed program for health system leaders looking to achieve the best-in-class care insulin injection experience for patients initiating insulin. These customized solutions focus on targeted improvements to standardize clinical best practices and eliminate variation in insulin initiation. The result is improved patient care, comfortable insulin experience, and improved clinical outcomes for those injecting insulin.
“For nearly 90 years, BD's culture of innovation and continuous improvement has enhanced the patient experience to enable better diabetes therapy and outcomes. We are glad that we are collaborating with Columbia Asia Hospitals to support their diabetes management program. BD has always taken a prominent role in educating doctors, allied healthcare professionals and patients on earlier initiation and better adherence to injectable therapies, thus helping people living with diabetes live healthier lives,” said Varun Khanna, managing director, BD-India.
The BD Getting Started program for Columbia Asia will have two objectives: to help clinicians initiate their patients to insulin therapy using a structured methodology; and to ensure adherence to therapy across the first nine months. The focus will be on customization and consistency of care through safe and comfortable insulin administration.